Equitable Holdings’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Equitable Holdings’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,226	Closed	-$346K	–	1082
2023 Q2	$346K	Sell	13,226 -6,205	-32%	-$164K	0.01%	806
2023 Q1	$519K	Buy	19,431 +3,825	+25%	+$103K	0.01%	640
2022 Q4	$428K	Buy	+15,606	New	+$415K	0.01%	653

Other funds holding FTXH

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

KNW

Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

OWA

Outlook Wealth Advisors Shenandoah, Texas $413M AUM 19.55% 1-Year Est. Return

Equitable Holdings's FTXH Position: Q3 2023 in Review

Equitable Holdings sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2023, closing a stake of 13,226 shares — an estimated $346K sold.

Equitable Holdings first reported a position in FTXH in Q4 2022 and held it in 3 quarters. The position peaked at $519K in Q1 2023. 19 funds tracked by Wall St. Rank hold FTXH as of Q3 2023.

Equitable Holdings reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q3 2023 after selling out during the quarter.
Equitable Holdings sold 13,226 First Trust Nasdaq Pharmaceuticals ETF shares in Q3 2023, an estimated $346K.
Equitable Holdings first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2022 and held it in 3 quarters.
Equitable Holdings's First Trust Nasdaq Pharmaceuticals ETF position peaked at $519K in Q1 2023.
19 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2023.

Based on Equitable Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.